Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
141,918,625
-
Share change
-
+3,087,744
-
Total reported value
-
$389,215,620
-
Put/Call ratio
-
293%
-
Price per share
-
$2.74
-
Number of holders
-
178
-
Value change
-
+$7,909,790
-
Number of buys
-
77
-
Number of sells
-
85
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2017
As of 31 Dec 2017,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
141,918,625 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, MACKENZIE FINANCIAL CORP, MORGAN STANLEY, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
178
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.